MAPT and metabolic disease: This compound has demonstrated antioxidant, anti‐inflammatory, and antihypertensive activity and has been used to treat metabolic disorders.[239, 240] A transgenic mouse model expressing P301S‐tau showed that quercetagitrin mitigates gliosis, neuronal loss, synaptic impairment, and cognitive deficits.